Biomatter is a Vilnius, Lithuania-based synthetic biology company using generative AI to design proteins and enzymes from scratch. Its Intelligent Architecture platform combines generative models with synthetic biology to create novel enzymes and proteins tailored for therapeutic, industrial, food, and environmental applications, spanning use cases where natural enzymes fall short. By generating sequences beyond the limits of natural evolution, Biomatter targets functions and conditions that conventional protein engineering cannot reach, then validates designs experimentally. The company partners with industrial and life-science organizations to bring AI-designed biocatalysts to market. Biomatter has drawn European venture and strategic backing to scale its generative design platform, positioning itself among Europe's emerging generative-biology players. Its mission is to make protein design programmable and broadly applicable across the bioeconomy.